The CEO expects strong international growth in injectable aesthetics in 2025, driven by neuromodulators and new market introductions. Refiling for Realfodi in the US is planned by end of 2025 with a focus on international growth for fillers.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay